SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
milu
Lv2
150 积分
2024-02-01 加入
最近求助
最近应助
互助留言
Cost‐effectiveness of first‐line versus second‐line use of domestic anti‐PD‐1 antibody sintilimab in Chinese patients with advanced or metastatic squamous non‐small cell lung cancer
1小时前
待确认
Cost-effectiveness analysis of first-line serplulimab plus chemotherapy for advanced squamous non-small-cell lung cancer in China: based on the ASTRUM-004 trial
1小时前
待确认
Cost-effectiveness analysis of first-line serplulimab plus chemotherapy for advanced squamous non-small-cell lung cancer in China: based on the ASTRUM-004 trial
4小时前
已完结
Elevated respiratory complications following robotic-assisted lobectomy: A national cohort analysis of 26,140 cases
2个月前
已关闭
Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States
2个月前
已完结
Cost‐effectiveness analysis of tislelizumab in combination with chemotherapy for the first‐line treatment of patients with metastatic or recurrent nasopharyngeal carcinoma in China
2个月前
已完结
Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin for first-line treatment of recurrent or metastatic nasopharyngeal carcinoma
2个月前
已完结
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: A cost-effectiveness analysis
2个月前
已完结
Cost-effectiveness analysis of gemcitabine plus cisplatin versus docetaxel, cisplatin and fluorouracil for induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma
2个月前
已完结
Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysis
2个月前
已完结
没有进行任何应助
不需要了【积分已退回】
2个月前
感谢
2个月前
感谢,点赞
2个月前
感谢,点赞
2个月前
感谢,点赞
2个月前
感谢,点赞
2个月前
感谢,点赞
2个月前
感谢
4个月前
感谢
4个月前
感谢,点赞,速度真快
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论